Omeros (OMER) Long-Term Investments (2015 - 2018)
Omeros recorded quarterly Long-Term Investments of $1.2 million in Q4 2018, down 80.22% quarter-over-quarter from $5.8 million in Q4 2017, and down 80.22% year-over-year from $5.8 million in Q4 2017.
Omeros' Long-Term Investments history runs 4 years deep, the most recent figure standing at $1.2 million for Q4 2018.
- In Q4 2018, Long-Term Investments fell 80.22% year-over-year to $1.2 million; the TTM figure through Dec 2018 stood at $1.2 million (down 80.22% YoY), while the FY2018 annual figure was $1.2 million, down 80.22% from the prior year.
- Long-Term Investments came in at $1.2 million for Q4 2018 at Omeros, down from $5.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $10.7 million in Q4 2015 to a low of $1.2 million in Q4 2018.
- A 4-year average of $5.9 million and a median of $5.8 million in 2016 frame the typical range for Long-Term Investments.
- Across the five-year window, Long-Term Investments changed 0.0% in 2017 and sank 80.22% in 2018, its largest moves.
- Omeros' Long-Term Investments stood at $10.7 million in 2015, then sank by 45.36% to $5.8 million in 2016, then changed by 0.0% to $5.8 million in 2017, then plunged by 80.22% to $1.2 million in 2018.
- According to Business Quant data, Long-Term Investments over the past three periods registered $1.2 million, $5.8 million, and $5.8 million for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 5.84 Mn |
| Dec 31, 2016 | 5.84 Mn |
| Dec 31, 2015 | 10.68 Mn |